Larimar Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Selling, General & Admin	14.09	12.28	12.07	11.4	2.42	13.19	12.16	18.29	19.2	8.14	Upgrade
Research & Development	27.67	24.25	38.4	31.41	20.79	47.93	40.84	39.94	54.62	27.39	Upgrade
Operating Expenses	41.76	36.53	50.47	42.8	23.21	61.12	53	58.23	73.81	35.53	Upgrade
Operating Income	-41.76	-36.53	-50.47	-42.8	-23.21	-61.12	-53	-58.23	-73.81	-35.53	Upgrade
Interest Expense / Income	0	0	0	0	0	1.9	0.17	0.53	0.81	0.87	Upgrade
Other Expense / Income	-4.81	-1.17	0.17	-0.32	-0.08	-1.65	-1.14	-0.88	-0.33	0.08	Upgrade
Pretax Income	-36.95	-35.36	-50.64	-42.48	-23.13	-61.37	-52.03	-57.88	-74.29	-36.48	Upgrade
Net Income	-36.95	-35.36	-50.64	-42.48	-23.13	-61.37	-52.03	-57.88	-74.29	-36.48	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	0	0.09	Upgrade
Net Income Common	-36.95	-35.36	-50.64	-42.48	-23.13	-61.37	-52.03	-57.88	-74.29	-36.57	Upgrade
Shares Outstanding (Basic)	44	26	17	12	6	3	2	2	2	1	Upgrade
Shares Outstanding (Diluted)	44	26	17	12	6	3	2	2	2	1	Upgrade
Shares Change	70.41%	50.09%	44.44%	95.09%	126.80%	17.48%	0.50%	2.03%	119.51%	1572.04%	Upgrade
EPS (Basic)	-0.84	-1.37	-2.95	-3.57	-3.80	-22.80	-22.80	-25.44	-33.36	-36.00	Upgrade
EPS (Diluted)	-0.84	-1.37	-2.95	-3.57	-3.80	-22.80	-22.80	-25.44	-33.36	-36.00	Upgrade
Free Cash Flow	-33.62	-27.67	-42.44	-42.26	-22.78	-51.6	-43.84	-52.64	-60.15	-28.3	Upgrade
Free Cash Flow Per Share	-0.77	-1.07	-2.47	-3.56	-3.74	-19.21	-19.18	-23.14	-26.98	-27.86	Upgrade
EBITDA	-36.64	-35.04	-50.3	-42.33	-23.05	-59.21	-51.68	-57.14	-73.41	-35.59	Upgrade
Depreciation & Amortization	0.31	0.32	0.34	0.16	0.08	0.26	0.19	0.21	0.07	0.02	Upgrade
EBIT	-36.95	-35.36	-50.64	-42.48	-23.13	-59.47	-51.86	-57.35	-73.48	-35.61	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).